2H96

Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun NH2-terminal Kinase Inhibitors


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free: 0.278 
  • R-Value Work: 0.225 
  • R-Value Observed: 0.243 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors.

Zhao, H.Serby, M.D.Xin, Z.Szczepankiewicz, B.G.Liu, M.Kosogof, C.Liu, B.Nelson, L.T.Johnson, E.F.Wang, S.Pederson, T.Gum, R.J.Clampit, J.E.Haasch, D.L.Abad-Zapatero, C.Fry, E.H.Rondinone, C.Trevillyan, J.M.Sham, H.L.Liu, G.

(2006) J Med Chem 49: 4455-4458

  • DOI: 10.1021/jm060465l
  • Primary Citation of Related Structures:  
    2H96

  • PubMed Abstract: 
  • C-Jun NH2 terminal kinases (JNKs) are important cell signaling enzymes. JNK1 plays a central role in linking obesity and insulin resistance. JNK2 and JNK3 may be involved in inflammatory and neurological disorders, respectively. Small-molecule JNK inhibitors could be valuable tools to study the therapeutic benefits of inhibiting these enzymes and as leads for potential drugs targeting JNKs ...

    C-Jun NH2 terminal kinases (JNKs) are important cell signaling enzymes. JNK1 plays a central role in linking obesity and insulin resistance. JNK2 and JNK3 may be involved in inflammatory and neurological disorders, respectively. Small-molecule JNK inhibitors could be valuable tools to study the therapeutic benefits of inhibiting these enzymes and as leads for potential drugs targeting JNKs. In this report, we disclose a series of potent and highly selective JNK inhibitors with good pharmacokinetic profiles.


    Related Citations: 
    • Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity.
      Szczepankiewicz, B.G., Kosogof, C., Nelson, L.T., Liu, G., Liu, B., Zhao, H., Serby, M.D., Xin, Z., Liu, M., Gum, R.J., Haasch, D.L., Wang, S., Clampit, J.E., Johnson, E.F., Lubben, T.H., Stashko, M.A., Olejniczak, E.T., Sun, C., Dorwin, S.A., Haskins, K., Abad-Zapatero, C., Fry, E.H., Hutchins, C.W., Sham, H.L., Rondinone, C.M., Trevillyan, J.M.
      (2006) J Med Chem 49: 3563
    • Synthesis and SAR of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as novel, selective c-Jun N-terminal kinase inhibitors.
      Liu, M., Xin, Z., Clampit, J.E., Wang, S., Gum, R.J., Haasch, D.L., Trevillyan, J.M., Abad-Zapatero, C., Fry, E.H., Sham, H.L., Liu, G.
      (2006) Bioorg Med Chem Lett 16: 2590

    Organizational Affiliation

    Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6098, USA. Hongyu.zhao@abbott.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Mitogen-activated protein kinase 8A, C [auth B]370Homo sapiensMutation(s): 2 
Gene Names: MAPK8JNK1PRKM8SAPK1SAPK1C
EC: 2.7.11.24
Find proteins for P45983 (Homo sapiens)
Explore P45983 
Go to UniProtKB:  P45983
NIH Common Fund Data Resources
PHAROS:  P45983
Protein Feature View
Expand
  • Reference Sequence
  • Find similar proteins by:  Sequence   |   Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
C-jun-amino-terminal kinase-interacting protein 1B [auth F], D [auth G]11N/AMutation(s): 0 
Find proteins for Q9UQF2 (Homo sapiens)
Explore Q9UQF2 
Go to UniProtKB:  Q9UQF2
NIH Common Fund Data Resources
PHAROS:  Q9UQF2
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 3 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
893
Query on 893

Download Ideal Coordinates CCD File 
G [auth A], K [auth B]5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE
C18 H19 N3 O4
VEGKZYFYGCWXMN-UHFFFAOYSA-N
 Ligand Interaction
SO4
Query on SO4

Download Ideal Coordinates CCD File 
E [auth A], F [auth A], I [auth B], J [auth B]SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
GOL
Query on GOL

Download Ideal Coordinates CCD File 
H [auth A], L [auth B]GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
893IC50:  230   nM  BindingDB
893IC50 :  230   nM  PDBBind
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free: 0.278 
  • R-Value Work: 0.225 
  • R-Value Observed: 0.243 
  • Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 155.66α = 90
b = 155.66β = 90
c = 125.163γ = 120
Software Package:
Software NamePurpose
ADSCdata collection
HKL-2000data reduction
CNXrefinement
HKL-2000data scaling
CNXphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2006-06-09 
  • Released Date: 2006-07-25 
  • Deposition Author(s): Abad-Zapatero, C.

Revision History  (Full details and data files)

  • Version 1.0: 2006-07-25
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Non-polymer description, Version format compliance